Exciting things are happening around the EvoNexus offices as COVID restrictions begin to loosen up here in California.
Random conversations in the aisles and in walks around the Franklin Templeton campus lead to new investor introductions and ideas for new potential markets
In-person visits by mentors are creating deeper relationships with the founding teams
Site visits by incubator applicants build up the excitement around admission
We look forward to formally welcoming EVERYONE back into the office soon – or, in the case of our newer startups, to the office for the first time! Keep an eye out for more information coming soon regarding our October Open House in San Mateo!
Even with onsite restrictions, 2021 has been an exciting year thus far for EvoNexus. Read on for details about:
The amazing and innovative companies we’ve admitted to our program
Our thriving portfolio companies who have closed funding rounds
Those that have reached milestones and been highlighted in the press
The continuing success of our alumni companies
We are particularly proud of the recently announced $800MM acquisition of Omniome (an EvoNexus 2017 company) by PacBio!
We are thrilled to announce the introduction of the following new startups into the EvoNexus portfolio of companies. Each company has undergone a rigorous due diligence process, and we look forward to closely supporting their development over their incubation lifecycle.
Imprint Energy, a new zinc battery technology to blend electronics into everyday things.
Neutroon, an all-in-one platform next-gen wireless (Private LTE/5G, Wi-Fi 6) that simplifies the setup and management of decentralized multi-vendor heterogenous networks including also a proprietary AI-based slicing technology.
Noonum, a SaaS technology that empowers investors to build and monitor custom portfolios for themes and trends.
Skeyeon, the creator of a high-resolution telescope that features incredibly low physical volume due to its 250km near earth orbit.
These companies currently in the EvoNexus incubators successfully closed their funding rounds this past quarter:
infima, a developer of deep learning technologies that enable mortgage security investors and dealers to identify valuable opportunities and reduce risk, secured a $2.8 million Series Seed led by Radical Ventures. Franklin Templeton and ThirdStream Partners also invested in the round.
Astrome, an E-band multi-beam wireless solution to 5G backhaul and rural broadband, raised $3.4 million from the Indian Angel Network Fund, Urania Ventures (Germany), Impact Collective (South Korea) and angel investors.
UCAP Power, Inc., a developer of ultracapacitor-based solutions across a range of renewable markets, closed a special purpose venture round let by Grantchester C Change.
Brelyon, an immersive yet compact (imagine a 122” 4K screen seen through a 32” aperture!) panoramic display that allows free head movement, raised $2 million led by Scalable displays, Type One Ventures and One Way Ventures.
QuSecure, a patented suite of software based post-quantum cybersecurity products, secured $1.6 million in pre-seed funding. Additionally, their partner Reliant, was awarded a $30 million contract with the Navy, making QuSecure a sub-prime contractor.
Lobus, a blockchain technology platform to track proof of ownership and centralize asset management for art, that has recently expanded to leverage NFTs to create innovative ownership structures, raised $6 million led by Upside Partnership, 8VC, Franklin Templeton, Dream Machine, Weekend Fund, and Boost VC, amongst others.
TurboSBIR, a software that simplifies complex federal grant submissions with Ai/ML-powered opportunity identification, application process automation, and expert guidance, secured a $1 million seed led by San Francisco-based VC, Govtech Fund. Longley Capital and General Inception also participated in the round, along with a few family offices and angels.
The Good Face Project, a platform to access ingredient transparency as well as R&D solutions for clean cosmetics, secured angel funding from Spark Growth Ventures.
These are some of the press stories about our current portfolio companies:
Lobus Co-Founder, Lori Hotz was named to Forbes 50 over 50, alongside the likes of Vice President Kamala Harris and CRISPR Co-inventor and Nobel Laureate, Jennifer Doudna.
Brelyon was recognized as the best prototype honoree of I-Zone at Display Week 2021. Display week is the biggest display conference in the world and the I-Zone section honors never-before-seen display technologies shown by start-ups and academic research laboratories around the world.
UCAP Power, Inc. acquired, amongst other Maxwell Technologies assets, the Maxwell brand, and the Maxwell Technologies Korea business.
Propel(x), an investment marketplace for Deep Tech innovation, is recognized as one of the 101 Top San Francisco Finance Companies and Startups in 2021, by BestStartups.us.
Farm Together, a platform to provide accredited investors with direct access to farmland, surpassed $100 million in AUM.
After leaving the Evonexus nest, many of our alumni companies go onto great success:
Omniome, Inc., a genomic Sequencing by Binding (SBB) platform, will be acquired by Pacific Biosciences for a total value of $800 million. According to BioSpace, the acquisition will uniquely position PacBio as the only company with both highly accurate long-read and short-read sequencing platforms.
Attack IQ, a cybersecurity company that provides companies with breach and attack simulation solutions, raised $44 million in Series C funding, led by Atlantic Bridge, Saudi Aramco Energy Ventures, and Gaingels, with existing vendors – Index Ventures, Khosla Ventures, Salesforce Ventures, and Telestra Ventures – also participating. This brings AttackIQ’s cumulative capital raised to $79 million.
Listen to what what founders in our current portfolio companies have to say about EvoNexus:
EvoNexus welcomes all FinTech, 5G / IoT / Telecomm, or MedTech startups to apply to our incubation program. Follow the link below to begin our application process. If this does not apply to you but to someone you know, please send them our way!
Our triumphs are a result of our close partnerships with the world’s leading influential companies in 5G, MedTech, and FinTech, as well as with angel, seed, and other early-stage investors! EvoNexus, as a non-profit, further succeeds thanks to the support we receive from our volunteers and selection committee members, and top providers of professional services. If you are involved with a company that should be connected with EvoNexus, click on the button below to connect with us.